• Telephone: (617) 945-5350
  • Sites:

Search for a Cure!

gl-1-thumb
gl-2-thumb
gl-3-thumb
gl-4-thumb
gl-5-thumb

  • SFAC Videos

Search For A Cure Recent Activity


Below are the Free nPEP Center's Provided by the MA Department of Public Health HIV Resource Guide.
If you think you have been exposed to HIV based on the guidelines in read more, please do not hesitate, find the center nearest you, call them and go there.
-
If you don' thave insurance you can get free nPEP at a center in the article.  If you have insurance then immediately go to your primary care physician. Medical professionals who are unsure if nPEP should be administered should call the National Clinicians' Post-Exposure Prophylaxis Hotline (PEPline) at 1-888-448-4911 for consultation.  Bring that number for your doctor, and print the CDC PEP Guidelines to bring as well.   Hotline staff will help determine if nPEP should be administered, and recommend a treatment regimen specific to the exposure and the source history (if available).
-
It is not worth waiting, particularly since so much can be done.
The key is getting treated as soon as possible.
If you live in Massachusetts, Click Read More and find the center and phone number right for you to call.
cover-banner

On April 16th a paper was published in Virology Journal that outlined the series of experiments utilized to attempt and determine the protective benefit, if any, that Cytolin could offer during in vitro experiments.  If an affect was discovered the goal was to determine the mechanism of action of that affect.  The laboratory of Dr. Eric Rosenberg by way of Jenna Reychert and team were able to demonstrate that Cytolin does offer protection from HIV, but through an unexpected route - the induction of an unidentified antiviral soluble factor.  Weird?  To try and help our audience interpret the published paper a little better we composed a series of graphic illustrations in an effort to make it more simple to follow the methodology used to discover what they did, and to illustrate some future steps.
Read More...

April 8th, 2013 - Why We Are So Into Antibodies - A Web Comic

mAb_webComic

If you are like me you may be saying to yourself, geez already is Search For A Cure stiiill talking about monoclonal antibodies - didn't they get that tested and figure out yet, com'on.  

The answer is no not yet, but we are a lot closer than we have been so far, and there are still really good reasons to persist! Some of which have been outlined in this web style comic to talk to a different audience and add a little flavor to the story line.

Enjoy! 
Read More...

February 1st, 2013 - ATAC's DDC Committee Meeting on Therapeutic Antibodies

feb1-2012_ATAC

In San Diego, CA Search For A Cure hosted a committee meeting of some of the best and brightest HIV/AIDS activists who have been egaged at the highest levels of patient advocacy and therapeutic development strategy since the early days of the epidemic.

The group, known as the AIDS Treatment Activists Coalition (ATAC), is a national coalition of AIDS activists - many living with HIV/AIDS - working together to end the AIDS epidemic by advancing research on HIV.  We brought them together with representation from CytoDyn Inc., the company responsible for the continued development of the monoclonal antibody PRO140, to discuss the entire field of monoclonal antibodies and their role as tools for combating HIV/AIDS.
Read More..

December 5th, 2012 - World AIDS Day Massachusetts State House PULSE Award Presentation

As we know World AIDS Day is officially on December 1st of each year.  For this past 2012 World AIDS Day event, Search was fortunate to be invited to participate in the planning and execution of the event at the MA State House along with many other representative groups and friends.  We were honored to have the opportunity to create the Search For A Cure PULSE Award and present it to Commissioner of Public Health John Auerbach for his years of service being responsible for the pulse of our community.  The reception was very warm, with of course somber notes of the sadness that brings us all together, but an important message of a bright future that lies ahead for all of us including our friend Commissioner Auerbach.  Read more to see pictures of the day. 
Read More..
Through a long and often misunderstood use antibodies have been instramental agents for the achievement of health, resistance, and immunization.  From the imbibment of toxins to garner resistance to their poisons by Mithridates the Sixth, to the discovery and classification of antibodies as the "Magic Bullet" by Paul Ehrlich in the early 1900's, to the now over 30 patented FDA approved monoclonal antibodies as therapeutic agents by the modern medical industry for centuries we have been leveraging this naturally binding agent for its high specificity to targets, gentle metabolization by the body, and long half-life.

This is the story of the history of antibodies, their use, the discovery of how to manipulate and design them for specific purposes, and their potential future and role as important therapeutic agents to ease the burden of treatment for HIV patients and to help in bringing about the end of transmission and the end of the HIV epidemic.

October 19th, 2012 - PRO140: A Game Changer for People with HIV

Major news to the world of HIV occured yesterday as the development of the monoclonal antibody PRO140 was extended beyond its original bearer, Progenics Pharmaceuticals, and has officially been acquired buy the cellular targeting antibody company CytoDyn Inc.  Following is the first in a series of articles illustrating the importance of PRO140 and antibodies like it to our community, and outlining our commitment to do outreach and education to rally support from the national and international community as monoclonal antibodies begin to take their place in HIV as they are doing in arthritis, cancer, and other autoimmune disease therapeutics. Read more to gain a more rich understanding of why we feel these therapies represent a new standard of care and must be pursued.  
Read More..
On January 13th, 2012 In light of the potential of antibodies as therapeutics and prevention for HIV infection, the MA Department of Public Health and Search For A Cure invited an expert panel to identify barriers to monoclonal antibody development and the best course of action to see them make a difference in the cause of ending the epidemic.  Following is a summary and the full transcript of that meeting including presentations on three likely candidates for monoclonal therapy Ibalizumab, PRO140, and Cytolin.  Please take the time to read more and educate yourself about this important topic.   

The National HIV strategy released out of Washington along with Bill Gate's annual letter on HIV and the CDC's  new High-Impact Approach to HIV Prevention have recommended exploratory commissions be created to evaluate and modernize state's treatment and transmission protocols in exactly this fashion.

Representative Sciortino's bill is an answer to that call.  The bill includes provisions not to touch any of the current funding for any programs but in fact to expand that funding and seek outside supplements to do so.

We believe along with our supporters that in light of new and presently underutilized, isolated, or underresourced technologies that this is the best strategy to align the fight against HIV in Massachusetts.

Read More...

March 26, 2011 - Annual New England Regional HIV Treatment and Prevention Conference
We had over 100 attendees and we are very grateful for everyones participation and support!  We have successfully loaded the powerpoint presentations by our wonderful speakers onto Slideshare.net and they are now available for you to preview and download to explore the topics more deeply on your own.  Click the images below to go to the corresponding slideshow at slideshare.

march_26_slide4march_26_slidemarch_26_slide2march_26_slide3
Add a comment

Search for a Cure's Affiliate and Associate Network

Our Motivation

After we eliminate HIV, there will be new biologic threats as there was in the past with Plague, SmallPox, Polio, Syphillis, etc. 

We are interested in getting better and faster at working together to eliminate these threats to our public well being.

Latest News

Most Popular

About SFAC, Inc.

Search For A Cure is an HIV/AIDS patient advocacy non-profit dedicated to seeing the end of HIV/AIDS globally by ensuring all people living with or affected by HIV has equal access to safe and affordable prevention, treatment, education, and care.

Contact Us

  • Address:   17 Worcestor St.  Cambridge, MA 02139  USA
  • Tel:            (617) 945-5350
  • Cel:           (617) 913-6189
  • Email:        chris@sfac.org
You are here: Home